
ProPhet uses AI to accelerate early drug discovery for difficult protein targets. The platform combines computational biology, chemistry, and machine learning to predict protein dynamics and how drug candidates interact. It analyzes large libraries of small molecules to rapidly identify promising candidates. Targeted at pharma and biotech R&D teams, it functions as an AI-driven platform in the B2B space. The approach aims to expand the druggable target space, offering faster, more cost-effective exploration of therapies.

ProPhet uses AI to accelerate early drug discovery for difficult protein targets. The platform combines computational biology, chemistry, and machine learning to predict protein dynamics and how drug candidates interact. It analyzes large libraries of small molecules to rapidly identify promising candidates. Targeted at pharma and biotech R&D teams, it functions as an AI-driven platform in the B2B space. The approach aims to expand the druggable target space, offering faster, more cost-effective exploration of therapies.